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M  yroides (Myroides spp.) is a non-fermentative, Gram-negative, rod-like bacteria and is widely distributed in nature [1]. Myroides is a rare opportunistic pathogen 
which has been reported to cause urinary tract infections 
(UTI), wound infection, and pneumonia septicemia among 
other infections [2-4]. Management of infections caused by 
Myroides can be challenging due to its high resistance to most 




A 58-year-old male, a known case of diabetes mellitus Type II, 
hypertension, and hypothyroidism, was admitted to the intensive 
care unit (ICU) for the left-sided cerebrovascular accident. 
During his hospital stay, tracheostomy tube, Foley’s catheter, 
Ryle’s tube, and peripheral venous line were in place. 4 days 
after hospitalization, the patient suffered an infectious episode 
due to Escherichia coli isolated from culture of endotracheal 
aspirate and was successfully treated with piperacillin-
tazobactam. 9 days after hospitalization, the patient developed 
symptoms of UTI and the investigations revealed hemoglobin 
(Hb) - 9.9 g/dl, total leukocyte count (TLC) – 15,400, 
sodium - 135 meq/L, potassium - 3.3 meq/L, urea - 36 mg/
dl, and creatinine - 0.9 mg/dl. The patient was started on 
ceftriaxone and imipenem. Cultures from tracheostomy tube 
and blood were sterile. Urine microscopy revealed 3–5 white 
blood cells (WBC)/hpf and urine culture yielded a growth of 
Myroides spp. The organism was resistant to all antibiotics 
tested except minocycline (minimum inhibitory concentration 
[MIC] <1 µg/mL) (Table 1). Foley’s catheter was removed and 
a condom catheter was used afterward. The patient recovered 
from the UTI after the removal of the Foley’s catheter and 
continuation of ongoing antimicrobial therapy only.
Case 2
A 55-year-old male, a known case of diabetes mellitus Type II 
and dilated cardiomyopathy, was admitted to the hospital 
with complaints of severe breathlessness at rest, dry cough, 
and reduced urine output. 3rd day after hospitalization, 
he developed urinary retention and fever. Suprapubic 
catheterization was done. Empirical treatment with ceftriaxone 
was started. Routine workup showed Hb - 11.3 g/dl, TLC – 
16,900, platelets - 2.34 lakh, Na - 132 meq/L, K - 2.6 meq/L, 
urea - 54 mg/dl, and creatinine - 1.4 mg/dl. Urine microscopy 
showed 20–30 WBCs/hpf and culture results showed growth of 
Myroides spp. The organism was resistant to all antibiotics tested 
except minocycline (MIC <1 mg/dl) (Table 1). The patient had 
symptomatic relief within 48 h of suprapubic catheterization. The 
patient left the hospital against medical advice and was lost to 
follow-up.
ABSTRACT
Myroides is a non-fermentative, Gram-negative rod-like bacteria. It is a rare opportunistic pathogen which has been reported to 
cause many serious infections. Management of infections caused by Myroides can be challenging due to its high resistance to 
most antibiotics. We report three cases of urinary tract infection (UTI) due to Myroides species in patients with diabetes mellitus 
Type II. Myroides spp. isolated were resistant to all the antibiotics tested: Amoxicillin-clavulanic acid, piperacillin-tazobactam, 
cefepime, ceftriaxone-cefoperazone sulbactam, amikacin, gentamicin, imipenem, meropenem, ciprofloxacin, colistin, tigecycline, 
and co-trimoxazole. Two strains were sensitive to minocycline (minimum inhibitory concentration <1 µg/mL). Two patients had 
Foley’s catheter in place and one patient had urinary retention at the time of diagnosis. The infection in two cases was nosocomial, 
whereas one case appeared to have a community-acquired infection with Myroides. Clinicians should consider the possibility of 
Myroides as a pathogen in UTI in diabetic patients, especially in nosocomial settings.
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Case 3
A 56-year-old male, a known case of chronic obstructive pulmonary 
disease (COPD) and diabetes mellitus Type II, was admitted to the 
ICU for exacerbation of COPD and altered sensorium. The patient 
was on ventilator and Foley’s catheter was in place. Culture from 
endotracheal aspirate yielded growth of Pseudomonas aeruginosa. 
Antibiotic therapy with piperacillin-tazobactam and gentamicin 
was started and the patient’s general condition improved. 3 days 
later, the patient developed acute kidney injury with hypernatremia 
(serum Na - 156 meq/L, K - 5.4 meq/L, urea - 143 mg/dl, and 
creatinine - 1.4 mg/dl). Hb  - 11.9  mg/dl, total leukocyte count - 
32,000/mm3, polymorphs - 70%, platelet count – 180,000/mm3. Blood 
culture results showed no growth after 7 days of aerobic incubation. 
Urine microscopy showed 2–3 WBCs/hpf and urine culture showed 
a growth of Myroides spp. Resistant to all antibiotics tested (Table 1). 
While awaiting culture results, the urea and creatinine levels of the 
patient worsened to 216 mg/dl and 2.4 mg/dl, respectively. Urinary 
catheter was removed and the patient was taken up for emergency 
hemodialysis. Patient’s condition stabilized and he recovered 
slowly. A sequential urine culture did not show any growth. He 
was discharged from the hospital 10 days later. It cannot be reliably 
said if the kidney failure was triggered by Myroides infection but 
in absence of any other identifiable cause and presence of pyuria 
pathogenic role of Myroides was assumed in this patient.
DISCUSSION
Myroides spp. has established itself as a true pathogen rather 
than only an environmental commensal over the years. Cases 
of Myroides causing UTI have been reported in patients with 
chronic nephritis, urinary retention, urinary calculi, and diabetes 
mellitus [6,7]. Nosocomial outbreaks of Myroides UTI have also 
been reported in the published literature [2,8]. Diabetes is one of 
the major risk factors associated with UTIs caused by Myroides. 
All of the three cases in our report were long-standing diabetics. 
A similar association was reflected in a recently published study 
from Apollo hospital, where 7 out of 13 cases of Myroides UTI 
had diabetes mellitus [7]. Another apparent risk factor in our 
patients is the presence of Foley’s catheter. It is possibly because 
of the strong tendency of Myroides spp. to form biofilms [9]. Due 
to the same reason, it is important to discriminate colonizations 
from true infection in case of Myroides. Decision to treat or not to 
treat becomes important in such cases. Hu et al. [6] reported that 
9/11 patients who were catheterized and had Myroides isolation from 
urine showed no pyuria. These patients were not treated and urine 
culture became negative after removal of catheter. Addressing this 
issue of diagnosing catheter associated asymptomatic bacteriuria 
(CA-ASB) and catheter associated UTI(CA-UTI), Infectious 
Disease Society of America (IDSA) published clinical practice 
guidelines in 2010 [10]. CA-UTI in patients with indwelling 
urethral, indwelling suprapubic, or intermittent catheterization 
is defined by the presence of symptoms or signs compatible 
with UTI with no other identified source of infection along with 
≥103 colony-forming units (cfu)/mL of ≥1 bacterial species in a 
single catheter urine specimen. All three of our patients had signs 
and symptoms compatible with CA-UTI as per the guidelines. 
Therefore, an antibiotic therapy was intended to be used.
In case of Myroides UTI, the susceptibility to various antibiotics 
reported in literature is quite variable. However, majority of reports 
Table 1: Antibiotic susceptibility profiles of the Myroides spp. isolated*
Case 1 Case 2 Case 3
Organism isolated from 
urine culture
Myroides spp. Myroides spp. Myroides spp.
Underlying risk factors Diabetes mellitus 
Type II, hypertension, 
hypothyroidism 
catheterization, ICU stay
Diabetes mellitus Type II, 
urinary retention
Diabetes mellitus Type II, COPD 
catheterization, ICU stay
Amox-clav R R R
Piperacillin-tazobactam R R R
Cefepime R R R
Ceftriaxone R R R
Cefoperazone-sulbactam R R R
Amikacin R R R
Gentamicin R R R
Imipenem R R R
Meropenem R R R
Ciprofloxacin R R R
Colistin R R R
Tigecycline R R R
TMP-SMX R R R
Minocycline S S -
*Identification and antibiotic susceptibility testing was done using VITEK®2 (bio Merieux, USA), as per the manufacturer’s instructions, R: Resistant, S: Sensitive. ICU: Intensive 
care unit, COPD: Chronic obstructive pulmonary disease, TMP-SMX: Trimethoprim-Sulfamethoxazole
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describe the Myroides isolates to be multi or pandrug resistant 
and difficult to treat and therefore with variable success. A case of 
nosocomial UTI in an end-stage renal disease patient reported from 
Taiwan was found to be sensitive to imipenem and piperacillin-
tazobactam and was successfully treated [11]. However, Solanki et 
al. [7] reported that all the isolates of Myroides recovered from urine 
were resistant to all the antibiotics tested. Similarly, Ktari et al. [8] 
isolated Myroides spp. from seven patients with UTI and all of them 
were resistant to all the antibiotics tested. Three of them could be 
successfully treated with ciprofloxacin and rifampicin therapy.
The Myroides isolates reported here were also resistant to all 
the antibiotics tested except minocycline in two cases. A case of 
Myroides causing urosepsis in an immunocompromised patient has 
been reported from Pune, recently, where the isolate was resistant 
to all antibiotics tested except minocycline. The patient, however, 
succumbed to the infection despite the antimicrobial therapy 
including minocycline [12]. There is a dearth of studies/reports 
exploring UTI due to Myroides in diabetic patients. We report a set 
of three cases of Myroides UTI in diabetes mellitus Type II patients 
here. The infection in Cases 1 and 3 was nosocomial, whereas Case 
2 appears to have a community-acquired infection. Indwelling 
catheter, urinary retention, and prolonged ICU stay might be the 
risk factors associated with Myroides infections in these cases. 
Our patients survived, but it is still difficult to say which modality 
helped them the most removal of Foley’s catheter/relieving urinary 
retention, antimicrobial therapy or both? A lacuna in the knowledge 
is thus apparent and the need of larger studies evident.
Hence, it should be kept in mind that Myroides is capable of 
causing serious infections in diabetic patients and is becoming 
increasingly common. Studies on Myroides infections in diabetic 
patients and effective treatment modalities can be taken up in the 
future.
CONCLUSION
Clinicians should consider the possibility of Myroides as a 
pathogen in urinary tract infections in diabetic patients especially 
in nosocomial settings.
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